Grants and Contributions:
Title:
Research and Development of HeartPrint bioink
Agreement Number:
981586
Agreement Value:
$25,000.00
Agreement Date:
Nov 1, 2021 - Apr 30, 2022
Description:
3D bioprinting enables the generation of human tissue models for screening potential drug targets in a more relevant fashion compared to animal models. This project is to perform the market research on what would be desirable features for the bioink capable of printing human cardiac tissues along with the initial R&D for this product.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Victoria, British Columbia, CA V8W 2Y2
Reference Number:
172-2021-2022-Q3-981586
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
740149539
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is -25,000 dollars.
Amendment Date
Mar 21, 2022
Recipient's Legal Name:
Axolotl Biosciences Inc.
Federal Riding Name:
Victoria
Federal Riding Number:
59041
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: